PALVELLA THERAPEUTICS, INC. (PVLA) insider buying and selling

NASDAQ: PVLA · Source: SEC Form 4 filings · Latest trade reported

In the last 90 days at PALVELLA THERAPEUTICS, INC. (PVLA), no insider made an open-market purchase and 2 insiders made 6 open-market sales worth $704K, as reported on SEC Form 4. 5 of the 6 sales were scheduled in advance or made to cover tax on vesting shares, so they say less about the insider's view of the stock. Over the last 12 months, 1 insider bought $50K of the stock, led by GEORGE M JENKINS (Director), who bought $50K on Mar 30, 2026; 2 insiders sold $1.8M, of which $1.8M was scheduled or tax-related.

Insider buys, 90 days
0
$0 · 0 insiders
Insider sales, 90 days
6
$704K · 2 insiders
Insider buys, 12 months
1
$50K · 1 insider
Insider sales, 12 months
13
$1.8M · 2 insiders

This is the public summary. Create a free account to see PVLA’s AI Signal, the price chart with every insider trade plotted, and each insider’s track record.

Unlock PVLA

Recent open-market insider trades

Trades by the same insider within a week are shown as one line.

Open-market insider trades at PALVELLA THERAPEUTICS, INC.
DateInsiderTypeSharesPriceValue
CHRISTOPHER P KIRITSY
Director
Open market sale313$157.00$49K
GEORGE M JENKINS
Director
Open market purchase445$112.30$50K

Scheduled and tax-related sales

Sales made under a pre-arranged 10b5-1 plan or to cover tax on vesting shares. They are listed separately because they are not a fresh decision to sell.

Scheduled and tax-related insider sales at PALVELLA THERAPEUTICS, INC.
DateInsiderTypeSharesPriceValue
Kathleen Goin
COO
10b5-1 sale
5 trades
4,302avg. $152.21$655K
Kathleen Goin
COO
10b5-1 sale
4 trades
4,302avg. $149.28$642K
Kathleen Goin
COO
10b5-1 sale
3 trades
4,302avg. $110.56$476K

What the PVLA insider trades really mean

The table above is the public summary. With an Insider Intel account you get the analysis behind it, for PALVELLA THERAPEUTICS, INC. and every other stock we track:

The AI Signal weighs:Insider buyingAnalyst ratingPrice upsideAI OutlookInsider track recordBreakout pressure

Plus AI summaries, the latest news for each stock, and an AI assistant you can ask questions about any of it.

Get started free with PVLA Insider Intel tracks insider activity at 3,154 companies right now. The Free plan includes full price charts and trade history, watchlists and email alerts.

Questions about PVLA insider trading

Who bought PALVELLA THERAPEUTICS, INC. (PVLA) stock recently?

Insiders who bought PALVELLA THERAPEUTICS, INC. stock on the open market in the last 12 months: GEORGE M JENKINS ($50K). The most recent purchase was reported on Mar 30, 2026.

Are insiders buying or selling PVLA?

Over the last 12 months insiders were roughly balanced between buying and selling of PVLA on discretionary trades: $50K bought against $49K sold (scheduled and tax-related sales excluded).

What is a sell-to-cover or 10b5-1 sale?

A 10b5-1 sale is scheduled in advance under a pre-arranged plan, and a sell-to-cover sale is made to pay tax on vesting shares. Neither is a fresh decision to sell, so they say less about an insider's view than a discretionary sale.

Where does this data come from?

Officers, directors and large shareholders report their trades to the SEC on Form 4. This page lists the open-market purchases and sales by individual insiders from those public filings; funds and other institutions are not shown.

Other stocks with recent insider buying

Ready to see PVLA in full?

Create a free account and open its chart, score and alerts.

Create your free account

How to read this page

Officers, directors and large shareholders must report their trades in company shares to the SEC on Form 4. This page lists open-market purchases and sales by individual insiders: trades made on the stock exchange at the going price. Funds and other institutions are not shown here.

Information from SEC EDGAR Form 4 filings, shown for general information only. It is not financial advice and does not recommend buying or selling any security. Trades are shown by transaction date and may be reported up to two business days later.